Deals and Data, Tim Ingersoll’s monthly waltz through the world of San Diego biotech, is making its rounds. Among the highlights in this month’s column is news from Amylin Pharmaceuticals and Arena Pharmaceuticals, two companies we wrote about Monday.

The Biocom spokesman also offers lots of other tidbits on everything from stock offerings to plant openings to drug successes and failures.


Click here for more from The Venture

Leave a comment

We expect all commenters to be constructive and civil. We reserve the right to delete comments without explanation. You are welcome to flag comments to us. You are welcome to submit an opinion piece for our editors to review.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.